Cargando…

The changing epidemiology of hepatitis B in Greece

BACKGROUND: The epidemiology of hepatitis B virus (HBV) infection has changed in recent years as a result of various factors. Our aim was to assess the epidemiological characteristics and the evolution of the HBV infection in a well-defined area of Greece. METHOD: Prospectively collected data from 1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rigopoulou, Eirini I., Gatselis, Nikolaos K., Galanis, Konstantinos, Lygoura, Vasiliki, Gabeta, Stella, Zachou, Kalliopi, Dalekos, George N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hellenic Society of Gastroenterology 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079866/ https://www.ncbi.nlm.nih.gov/pubmed/33948070 http://dx.doi.org/10.20524/aog.2021.0614

Ejemplares similares

FibroMeter scores are predictive noninvasive markers of advanced and significant liver fibrosis in patients with chronic viral hepatitis or metabolic dysfunction-associated steatotic liver disease
por: Arvaniti, Pinelopi, et al.
Publicado: (2023)

Long-term results of mycophenolate mofetil vs. azathioprine use in individuals with autoimmune hepatitis
por: Dalekos, George N., et al.
Publicado: (2022)

First Results From a Propensity Matching Trial of Mycophenolate Mofetil vs. Azathioprine in Treatment-Naive AIH Patients
por: Dalekos, George N., et al.
Publicado: (2022)

Total and individual PBC-40 scores are reliable for the assessment of health-related quality of life in Greek patients with primary biliary cholangitis
por: I. Rigopoulou, Eirini, et al.
Publicado: (2023)

Patients with Haemoglobinopathies and Chronic Hepatitis C: A Real Difficult to Treat Population in 2016?
por: Zachou, Kalliopi, et al.
Publicado: (2017)

Serum Cartilage Oligomeric Matrix Protein and Golgi Protein-73: New Diagnostic and Predictive Tools for Liver Fibrosis and Hepatocellular Cancer?
por: Gatselis, Nikolaos K., et al.
Publicado: (2021)

Efficient management of secondary haemophagocytic lymphohistiocytosis with intravenous steroids and γ-immunoglobulin infusions
por: Georgiadou, Sarah, et al.
Publicado: (2019)

Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease
por: Zachou, Kalliopi, et al.
Publicado: (2004)

The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders
por: Papamichalis, Panagiotis A, et al.
Publicado: (2007)

Belimumab is a promising third-line treatment option for refractory autoimmune hepatitis
por: Arvaniti, Pinelopi, et al.
Publicado: (2020)

Early Primary Biliary Cirrhosis: A New Association with Erythema Nodosum of Unknown Origin
por: Gatselis, Nikolaos K., et al.
Publicado: (2010)

Severe Pharyngodynia Followed by Migratory Polyarthritis and High Fever in Young Immigrants: Remember That Rheumatic Fever Is Still Relevant in 2020!
por: Azariadis, Kalliopi, et al.
Publicado: (2020)

Acute non-A, non-B, non-C hepatitis differences and similarities between hepatitis E virus infection and autoimmune hepatitis, with phylogenetic analysis of hepatitis E virus in humans and wild boars
por: Zachou, Kalliopi, et al.
Publicado: (2022)

Golgi protein-73: A biomarker for assessing cirrhosis and prognosis of liver disease patients
por: Gatselis, Nikolaos K, et al.
Publicado: (2020)

Lessons from pathophysiology: Use of individualized combination treatments with immune interventional agents to tackle severe respiratory failure in patients with COVID-19
por: Dalekos, George N., et al.
Publicado: (2021)

Low Serum Hepcidin in Patients with Autoimmune Liver Diseases
por: Lyberopoulou, Aggeliki, et al.
Publicado: (2015)

Hepcidin as a Sensitive and Treatment-Responsive Acute-Phase Marker in Patients with Bacteremia: A Pilot Study
por: Koukoulas, Kreon, et al.
Publicado: (2022)

Programmed cell death-1 rs11568821 and interleukin-28B rs12979860 polymorphisms in autoimmune hepatitis
por: Gatselis, Nikolaos K., et al.
Publicado: (2021)

Soluble IL-2R Levels at Baseline Predict the Development of Severe Respiratory Failure and Mortality in COVID-19 Patients
por: Gatselis, Nikolaos K., et al.
Publicado: (2022)

Epigenetic Modifications in Generalized Autoimmune Epithelitis: Sjögren’s Syndrome and Primary Biliary Cholangitis
por: Arvaniti, Pinelopi, et al.
Publicado: (2019)

Promyelocytic Leukemia Antigen Expression: a Histological Marker for Primary Biliary Cholangitis Diagnosis?
por: Papamichalis, Panagiotis A., et al.
Publicado: (2021)

Impact of genetic and environmental factors on autoimmune hepatitis
por: Zachou, Kalliopi, et al.
Publicado: (2021)

Postinfantile Giant Cell Hepatitis with Features of Acute Severe Autoimmune Hepatitis Probably Triggered by Diclofenac in a Patient with Primary Myelofibrosis
por: Arvaniti, Pinelopi, et al.
Publicado: (2018)

Ocular disorders as the prevailing manifestations of antiphospholipid syndrome: a case series
por: Tsironi, Evangelia, et al.
Publicado: (2009)

Spontaneous bacterial peritonitis: a prospective Greek multicenter study of its epidemiology, microbiology, and outcomes
por: Samonakis, Dimitrios N., et al.
Publicado: (2022)

Autoimmune hepatitis-specific antibodies against soluble liver antigen and liver cytosol type 1 in patients with chronic viral hepatitis
por: Rigopoulou, Eirini I, et al.
Publicado: (2007)

Plethora of Resistance Genes in Carbapenem-Resistant Gram-Negative Bacteria in Greece: No End to a Continuous Genetic Evolution
por: Tsilipounidaki, Katerina, et al.
Publicado: (2022)

Current Trends and Characteristics of Hepatocellular Carcinoma in Patients with Autoimmune Liver Diseases
por: Rigopoulou, Eirini I., et al.
Publicado: (2021)

Safety and Efficacy of Transcatheter Arterial Chemoemboliazation in the Real-Life Management of Unresectable Hepatocellular Carcinoma
por: Mazioti, Argyro, et al.
Publicado: (2013)

An Immunocompetent HIV-Negative Elderly Patient with Low-Grade Fever, Generalized Lymphadenopathy, Splenomegaly, and Acute Phase Response: Do Not Forget Castleman Disease
por: Azariadis, Kalliopi, et al.
Publicado: (2021)

Management of Patients with Liver Cirrhosis and Invasive Bladder Cancer: A Case-series
por: Zachos, Ioannis, et al.
Publicado: (2019)

Treatment responses and outcomes in patients with autoimmune hepatitis and concomitant features of non-alcoholic fatty liver disease
por: Zachou, Kalliopi, et al.
Publicado: (2023)

New Data concerning the Epidemiology of Hepatitis B Virus Infection in Greece
por: Pantazis, Konstantinos D., et al.
Publicado: (2008)

An immunocompetent patient presenting with severe septic arthritis due to Ralstonia pickettii identified by molecular-based assays: a case report
por: Makaritsis, Konstantinos P, et al.
Publicado: (2009)

Histological activity despite normal ALT and IgG serum levels in patients with autoimmune hepatitis and cirrhosis
por: Laschtowitz, Alena, et al.
Publicado: (2021)

Changing Epidemiology of Tinea Capitis in Athens, Greece: The Impact of Immigration and Review of Literature
por: Charpantidis, Stefanos, et al.
Publicado: (2023)

Unusual cardiovascular complications of brucellosis presenting in two men: two case reports and a review of the literature
por: Gatselis, Nikolaos K, et al.
Publicado: (2011)

Epidemiology of hepatitis C in Greece
por: Triantos, Christos, et al.
Publicado: (2016)

Aiming towards hepatitis C virus elimination in Greece
por: Papatheodoridis, George V., et al.
Publicado: (2019)

Monitoring and comorbidities in patients with chronic hepatitis B currently treated with nucleos(t)ide analogs
por: Siakavellas, Spyros, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fk0cor23unsqiusq9epcvu3p0j